Free Trial
Jeff Johnson

Jeff Johnson Analyst Performance

Senior Research Analyst at Robert W. Baird

Jeff Johnson is a stock analyst at Robert W. Baird focused in the medical sector, covering 18 publicly traded companies. Over the past year, Jeff Johnson has issued 15 stock ratings, including buy and hold recommendations. While full access to Jeff Johnson's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jeff Johnson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
58 Last 10 Years
Buy Recommendations
61.82% 34 Buy Ratings
Companies Covered
18 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy61.8%34 ratings
Hold38.2%21 ratings
Sell0.0%0 ratings

Out of 55 total stock ratings issued by Jeff Johnson at Robert W. Baird, the majority (61.8%) have been Buy recommendations, followed by 38.2% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
72.2% of companies on NASDAQ
13 companies
NYSE
27.8% of companies on NYSE
5 companies

Jeff Johnson, an analyst at Robert W. Baird, currently covers 18 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
17 companies
94.4%
Miscellaneous
1 company
5.6%

Jeff Johnson of Robert W. Baird specializes in stock coverage within the Medical sector, with additional focus on companies.

Coverage Industries

IndustryPercentage
MED PRODUCTS
6 companies
33.3%
MED/DENTAL - SUPP
4 companies
22.2%
MED INSTRUMENTS
4 companies
22.2%
MEDICAL & HOSPITAL EQUIPMENT
1 company
5.6%
MEDICAL DEVICES
1 company
5.6%
Miscellaneous
1 company
5.6%
ELECTROMEDICAL EQUIPMENT
1 company
5.6%

About Jeff Johnson

Jeff Johnson is Baird’s Senior Research Analyst covering Medical Technology. In recent years, Jeff has been recognized in the StarMine Analyst Awards by Refinitiv as the No. 2 stock picker in Health Care Equipment & Supplies (2020) and was ranked by TipRanks as the fourth best Wall Street analyst in 2018 and as a Top 100 Wall Street analyst in 2019. Jeff has also been named one of the Top 32 Most Influential People in Dentistry by Incisal Edge for three years running (from 2019-2021). Prior to joining Baird in 2003, Jeff was an optometrist and the associate director of Refractive Surgery Services at the Massachusetts Eye and Ear Infirmary and earlier in his career held positions as an instructor of ophthalmology at Harvard Medical School and an adjunct-assistant professor of optometry at the New England College of Optometry. He received his MBA from Northwestern University, graduated from the Illinois College of Optometry, and did his undergraduate work at the University of Illinois at Urbana-Champaign.
Follow on LinkedIn

Jeff Johnson's Ratings History at Robert W. Baird

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
8/28/2025Lower Price Target$64.87$85.00Outperform
Alcon stock logo
ALC
Alcon
8/21/2025Lower Price Target$79.29$95.00Outperform
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
7/30/2025Set Price Target$16.05$17.00Neutral
Henry Schein, Inc. stock logo
HSIC
Henry Schein
7/14/2025Reiterated Rating$73.42$72.00Neutral
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
5/30/2025Lower Price Target$68.87$97.00Outperform
Envista Holdings Corporation stock logo
NVST
Envista
5/27/2025Upgrade$16.73$23.00Outperform
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
5/6/2025Lower Price Target$90.34$115.00Outperform
Envista Holdings Corporation stock logo
NVST
Envista
5/2/2025Set Price Target$17.00$21.00
DexCom, Inc. stock logo
DXCM
DexCom
5/2/2025Lower Price Target$70.26$105.00Outperform
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
5/1/2025Lower Price Target$16.85$24.00Neutral
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
3/7/2025Lower Price Target$90.98$107.00Outperform
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2/27/2025Lower Price Target$33.59$33.00Neutral
Alcon stock logo
ALC
Alcon
2/27/2025Boost Price Target$93.26$108.00Outperform
Beta Bionics, Inc. stock logo
BBNX
Beta Bionics
2/20/2025Initiated Coverage$21.81$20.00Neutral
DexCom, Inc. stock logo
DXCM
DexCom
1/16/2025Upgrade$80.40$104.00Outperform